There is no evidence that legalised physician assisted suicide, results in disproportionate numbers of vulnerable people having their lives ended prematurely by doctors, finds research in the Journal of Medical Ethics .
The European Commission has approved Exelon® patch (rivastigmine transdermal patch), an innovative way to deliver this effective medicine to patients suffering from mild to moderately severe Alzheimer’s disease.
The University of Rochester Medical Center received $1.5 million to develop a blood test for concussions by isolating proteins that can predict memory loss, chronic headaches or other neurological problems.
On World Alzheimer’s Day, the Alzheimer Society of Canada is pleased to announce its receipt of a $1 million legacy gift.
In the early stages of Alzheimer’s disease, people experience mild memory loss and confusion. These challenges are significant, but people often maintain much of their normal capability and spirit. Now, a specialized support group program is being formed at the UCSF Memory and Aging Center to help patients learn how to live with the disease and to help family members grieve and adjust.
While obesity has been shown to contribute to high blood pressure, heart disease and diabetes, being overweight in old age does not lead to memory problems, according to a study published September 19, 2007, in the online edition of Neurology®, the medical journal of the American Academy of Neurology.
Defects on cell-surface sugars may promote the short-term inflammation and long-term neurodegeneration that occurs in the central nervous system of multiple sclerosis patients, according to University of California, Irvine researchers.
Despite the huge publicity generated by a 2002 study on the potential dangers of hormone therapy for postmenopausal women, new research from the Stanford University School of Medicine found that only 29 percent of women surveyed knew about the study two years later.
HIV patients with declining platelet counts appear to be at increased risk for HIV?associated dementia, according to a report in the September issue of Archives of Neurology, one of the JAMA/Archives journals.
Researchers have found surprising evidence that an antidepressant (citalopram) may perform as well as a commonly prescribed antipsychotic (risperidone) in the alleviation of severe agitation and psychotic symptoms of dementia. Researchers also found that the antidepressant was associated with “significantly lower” adverse side effects.